Home/Filings/4/0001127602-16-062473
4//SEC Filing

AMGEN INC 4

Accession 0001127602-16-062473

$AMGNCIK 0000318154operating

Filed

Sep 12, 8:00 PM ET

Accepted

Sep 13, 6:21 PM ET

Size

8.3 KB

Accession

0001127602-16-062473

Insider Transaction Report

Form 4
Period: 2016-09-09
Transactions
  • Tax Payment

    Common Stock

    2016-09-09$170.97/sh2,604$445,20618,567 total
  • Exercise/Conversion

    Common Stock

    2016-09-09$71.64/sh+5,000$358,20021,171 total
  • Exercise/Conversion

    Nqso (Right to Buy)

    2016-09-095,0000 total
    Exercise: $71.64From: 2012-04-27Exp: 2022-04-27Common Stock (5,000 underlying)
Footnotes (1)
  • [F1]These shares include 203 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Director Incentive Program, as amended, under the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred Restricted Stock Units and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.

Issuer

AMGEN INC

CIK 0000318154

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000318154

Filing Metadata

Form type
4
Filed
Sep 12, 8:00 PM ET
Accepted
Sep 13, 6:21 PM ET
Size
8.3 KB